Savara (SVRA) Enterprise Value Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Savara 1.30 Bn 1.30 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -20.89%
Dec 31, 2025 -23.26%
Sep 30, 2025 2.46%
Jun 30, 2025 -0.92%
Mar 31, 2025 -4.36%
Dec 31, 2024 -6.80%
Sep 30, 2024 -8.71%
Jun 30, 2024 12.37%
Mar 31, 2024 9.45%
Dec 31, 2023 -25.46%
Sep 30, 2023 -21.30%
Jun 30, 2023 -1.80%
Mar 31, 2023 -3.02%
Dec 31, 2022 -1.11%
Sep 30, 2022 -8.04%
Jun 30, 2022 -8.43%
Mar 31, 2022 -13.01%
Dec 31, 2021 -13.29%
Sep 30, 2021 -15.09%
Jun 30, 2021 -34.21%
Mar 31, 2021 -31.38%
Dec 31, 2020 4.48%
Sep 30, 2020 -20.96%
Jun 30, 2020 -17.68%
Mar 31, 2020 -115.68%
Dec 31, 2019 -108.81%
Sep 30, 2019 -89.93%
Jun 30, 2019 -99.56%
Mar 31, 2019 -64.75%
Dec 31, 2018 -87.99%
Sep 30, 2018 -51.53%
Jun 30, 2018 -52.17%
Mar 31, 2018 -44.90%
Dec 31, 2017 -95.16%
Sep 30, 2017 -27.05%
Jun 30, 2017 -32.35%
Mar 31, 2017 29.49%
Dec 31, 2016 19.55%
Sep 30, 2016 19.94%
Jun 30, 2016 35.92%
Mar 31, 2016 9.76%
Dec 31, 2015 22.98%
Sep 30, 2015 6.89%
Jun 30, 2015 21.03%
Mar 31, 2015 15.35%
Dec 31, 2014 36.98%
Sep 30, 2014 12.13%
Jun 30, 2014 14.34%
Mar 31, 2014 13.77%
Dec 31, 2013 2.82%
Sep 30, 2013 -1.01%
Jun 30, 2013 -19.69%